Sarosh Irani
Are Predictors for Overall Mortality in COPD Patients Robust over Time?
Sievi N, Sepin J, Roeder M, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Clarenbach C, Kohler M. Are Predictors for Overall Mortality in COPD Patients Robust over Time?. J Clin Med 2023; 12
Feb 16, 2023Are Predictors for Overall Mortality in COPD Patients Robust over Time?
Feb 16, 2023J Clin Med 2023; 12
Sievi Noriane Andrina, Sepin Jerome, Roeder Maurice, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Joerg Daniel, Thurnheer Robert, Clarenbach Christian F, Kohler Malcolm
Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers
Huebner S, Leuppi-Taegtmeyer A, Kohler M, Trendelenburg M, Thurnheer R, Sievi N, Irani S, Heijnen I, Frey M, Egli A, Dieterle T, Clarenbach C, Chhajed P, Brutsche M, Brack T, Giezendanner S, Henny S, Leuppi J. Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers. Respiration 2021:1-14.
Dec 23, 2021Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers
Dec 23, 2021Respiration 2021:1-14
Huebner Simona Tabea, Leuppi-Taegtmeyer Anne Barbara, Kohler Malcolm, Trendelenburg Marten, Thurnheer Robert, Sievi Noriane Andrina, Irani Sarosh, Heijnen Ingmar, Frey Martin, Egli Adrian, Dieterle Thomas, Clarenbach Christian, Chhajed Prashant, Brutsche Martin, Brack Thomas, Giezendanner Stéphanie, Henny Simona, Leuppi Joerg Daniel
Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
Grewe F, Clarenbach C, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Roeder M, Bradicich M, Sievi N, Kohler M. Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD. Int J Chron Obstruct Pulmon Dis 2020; 15:627-635.
Mar 26, 2020Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
Mar 26, 2020Int J Chron Obstruct Pulmon Dis 2020; 15:627-635
Grewe Fabian A, Clarenbach Christian F, Thurnheer Robert, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Roeder Maurice, Bradicich Matteo, Sievi Noriane A, Kohler Malcolm
Handgrip Strength Seems Not to Be Affected by COPD Disease Progression: A Longitudinal Cohort Study
Kohlbrenner D, Kohler M, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Roeder M, Sievi N, Clarenbach C. Handgrip Strength Seems Not to Be Affected by COPD Disease Progression: A Longitudinal Cohort Study. COPD 2020; 17:150-155.
Feb 19, 2020Handgrip Strength Seems Not to Be Affected by COPD Disease Progression: A Longitudinal Cohort Study
Feb 19, 2020COPD 2020; 17:150-155
Kohlbrenner Dario, Kohler Malcolm, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Joerg D, Thurnheer Robert, Roeder Maurice, Sievi Noriane A, Clarenbach Christian F
"Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD
Sievi N, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Kohler M, Clarenbach C. "Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD. Respir Res 2020; 21:27.
Jan 20, 2020"Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD
Jan 20, 2020Respir Res 2020; 21:27
Sievi Noriane A, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Jörg D, Thurnheer Robert, Kohler Malcolm, Clarenbach Christian F
No impact of exacerbation frequency and severity on the physical activity decline in COPD: a long-term observation
Sievi N, Kohler M, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Clarenbach C. No impact of exacerbation frequency and severity on the physical activity decline in COPD: a long-term observation. Int J Chron Obstruct Pulmon Dis 2019; 14:431-437.
Feb 15, 2019No impact of exacerbation frequency and severity on the physical activity decline in COPD: a long-term observation
Feb 15, 2019Int J Chron Obstruct Pulmon Dis 2019; 14:431-437
Sievi Noriane A, Kohler Malcolm, Thurnheer Robert, Leuppi Joerg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Clarenbach Christian F
Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years
Sievi N, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Kohler M, Clarenbach C. Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years. Respir Med 2018; 141:1-6.
Jun 18, 2018Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years
Jun 18, 2018Respir Med 2018; 141:1-6
Sievi Noriane A, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Jörg D, Thurnheer Robert, Kohler Malcolm, Clarenbach Christian F
Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD
Sievi N, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Kohler M, Clarenbach C. Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD. Int J Chron Obstruct Pulmon Dis 2017; 12:1113-1118.
Apr 10, 2017Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD
Apr 10, 2017Int J Chron Obstruct Pulmon Dis 2017; 12:1113-1118
Sievi Noriane A, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Jörg D, Thurnheer Robert, Kohler Malcolm, Clarenbach Christian F
Determinants of annual change in physical activity in COPD
Clarenbach C, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Haile S, Sievi N, Kohler M. Determinants of annual change in physical activity in COPD. Respirology 2017; 22:1133-1139.
Mar 30, 2017Determinants of annual change in physical activity in COPD
Mar 30, 2017Respirology 2017; 22:1133-1139
Clarenbach Christian F, Thurnheer Robert, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Haile Sarah R, Sievi Noriane A, Kohler Malcolm
Impact of comorbidities on physical activity in COPD
Sievi N, Kohler M, Franzen D, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Senn O, Clarenbach C. Impact of comorbidities on physical activity in COPD. Respirology 2015; 20:413-8.
Jan 6, 2015Impact of comorbidities on physical activity in COPD
Jan 6, 2015Respirology 2015; 20:413-8
Sievi Noriane A, Kohler Malcolm, Franzen Daniel, Thurnheer Robert, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Senn Oliver, Clarenbach Christian F
Accuracy of the hospital anxiety and depression scale for identifying depression in chronic obstructive pulmonary disease patients
Nowak C, Thurnheer R, Rüdiger J, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Schlatzer C, Schwarz E, Clarenbach C, Sievi N, Kohler M. Accuracy of the hospital anxiety and depression scale for identifying depression in chronic obstructive pulmonary disease patients. Pulm Med 2014; 2014:973858.
Dec 4, 2014Accuracy of the hospital anxiety and depression scale for identifying depression in chronic obstructive pulmonary disease patients
Dec 4, 2014Pulm Med 2014; 2014:973858
Nowak Christoph, Thurnheer Robert, Rüdiger Jochen, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Schlatzer Christian, Schwarz Esther Irene, Clarenbach Christian F, Sievi Noriane A, Kohler Malcolm
Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
Albrich W, Conca A, Schäfer P, Schubert M, De Geest S, Reutlinger B, Irani S, Bürgi U, Huber A, Guglielmetti M, Schild U, Rüegger K, Dusemund F, Schuetz P, Arici B, Litke A, Blum C, Bossart R, Regez K, Müller B. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial. Eur Respir J. 2013; 42:1064-75.
Jan 24, 2013Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
Jan 24, 2013Eur Respir J. 2013; 42:1064-75
Albrich Werner, Conca Antoinette, Schäfer Petra, Schubert Maria, De Geest Sabina, Reutlinger Barbara, Irani Sarosh, Bürgi Ulrich, Huber Andreas, Guglielmetti Merih, Schild Ursula, Rüegger Kristina, Dusemund Frank, Schuetz Philipp, Arici Birsen, Litke Alexander, Blum Claudine A, Bossart Rita, Regez Katharina, Müller Beat
Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
Albrich W, Mueller B, Reutlinger B, Buergi U, Irani S, Bregenzer T, Zimmerli W, Christ-Crain M, Rüegger K, Dusemund F, Schuetz P. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011; 11:112.
May 3, 2011Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
May 3, 2011BMC Infect Dis 2011; 11:112
Albrich Werner, Mueller Beat, Reutlinger Barbara, Buergi Ulrich, Irani Sarosh, Bregenzer Thomas, Zimmerli Werner, Christ-Crain Mirjam, Rüegger Kristina, Dusemund Frank, Schuetz Philipp